151 related articles for article (PubMed ID: 10432950)
61. Heparin-induced thrombocytopenia: cross-reactivity between standard heparin, low molecular weight heparin, dalteparin (Fragmin) and heparinoid, danaparoid (Orgaran).
Ramakrishna R; Manoharan A; Kwan YL; Kyle PW
Br J Haematol; 1995 Nov; 91(3):736-8. PubMed ID: 8555084
[TBL] [Abstract][Full Text] [Related]
62. Comparing subcutaneous danaparoid with intravenous unfractionated heparin for the treatment of venous thromboembolism. A randomized controlled trial.
de Valk HW; Banga JD; Wester JW; Brouwer CB; van Hessen MW; Meuwissen OJ; Hart HC; Sixma JJ; Nieuwenhuis HK
Ann Intern Med; 1995 Jul; 123(1):1-9. PubMed ID: 7539233
[TBL] [Abstract][Full Text] [Related]
63. Delayed cutaneous reaction to unfractionated heparin, low molecular weight heparin and danaparoid.
Sivakumaran M; Ghosh K; Munks R; Gelsthorpe K; Tan L; Wood JK
Br J Haematol; 1994 Apr; 86(4):893-4. PubMed ID: 7802799
[No Abstract] [Full Text] [Related]
64. Delayed-type skin reaction to the heparin-alternative danaparoid.
Szolar-Platzer C; Aberer W; Kränke B
J Am Acad Dermatol; 2000 Nov; 43(5 Pt 2):920-2. PubMed ID: 11044823
[TBL] [Abstract][Full Text] [Related]
65. [Heparin-induced thrombocytopenia--a serious complication within the scope of heparin therapy. Follow-up of 7 trauma surgery patients].
Kuhn B
Unfallchirurg; 1997 Aug; 100(8):646-51. PubMed ID: 9381213
[TBL] [Abstract][Full Text] [Related]
66. Risk factors for bleeding during treatment of acute venous thromboembolism.
Wester JP; de Valk HW; Nieuwenhuis HK; Brouwer CB; van der Graaf Y; Meuwissen OJ; Hart HC; Sixma JJ; Banga JD
Thromb Haemost; 1996 Nov; 76(5):682-8. PubMed ID: 8950773
[TBL] [Abstract][Full Text] [Related]
67. [Loss of extremities caused by heparin-induced thrombocytopenia].
Wenzl ME; Leffringhausen W; Scherlitzky L
Unfallchirurg; 1996 Aug; 99(8):607-11. PubMed ID: 8975383
[TBL] [Abstract][Full Text] [Related]
68. [Heparin-induced thrombocytopenia occurring after surgical treatment of atrial myxoma--a case report].
Djunić I; Tomin D; Antonijević N; Gradinac S; Kovac M; Vidović A; Djurasinović V; Elezović I
Srp Arh Celok Lek; 2009; 137(9-10):540-4. PubMed ID: 19950764
[TBL] [Abstract][Full Text] [Related]
69. Management of allergy to heparins in postoperative care: subcutaneous allergy and intravenous tolerance.
Seitz CS; Brocker EB; Trautmann A
Dermatol Online J; 2008 Sep; 14(9):4. PubMed ID: 19061586
[TBL] [Abstract][Full Text] [Related]
70. Intraoperative monitoring of danaparoid sodium anticoagulation during cardiovascular operations.
Gitlin SD; Deeb GM; Yann C; Schmaier AH
J Vasc Surg; 1998 Mar; 27(3):568-75. PubMed ID: 9546248
[TBL] [Abstract][Full Text] [Related]
71. Development of a high-pressure liquid chromatography method for diagnosis of heparin-induced thrombocytopenia.
Koch S; Harenberg J; Odel M; Schmidt-Gayk H; Walch S; Budde U
Am J Clin Pathol; 2002 Jun; 117(6):900-4. PubMed ID: 12047141
[TBL] [Abstract][Full Text] [Related]
72. Use of Org 10,172 in the treatment of heparin-induced thrombocytopenia and thrombosis.
Kiers L; Grigg LE; Cade JF; Street PR; Chong BH
Aust N Z J Med; 1986 Oct; 16(5):719. PubMed ID: 3469977
[No Abstract] [Full Text] [Related]
73. [Treatment of disseminated intravascular coagulation].
Koyama T
Rinsho Ketsueki; 2010 Jan; 51(1):52-6. PubMed ID: 20134140
[No Abstract] [Full Text] [Related]
74. Additional anticoagulant strategies for managing heparin-induced thrombocytopenia.
Nawarskas JJ; Spinler SA
Am J Health Syst Pharm; 1996 Apr; 53(8):945. PubMed ID: 8728386
[No Abstract] [Full Text] [Related]
75. Successful pregnancy after pulmonary embolism and heparin-induced thrombocytopenia--case report.
Plesinac S; Babović I; Karapandzić VP
Clin Exp Obstet Gynecol; 2013; 40(2):307-8. PubMed ID: 23971268
[TBL] [Abstract][Full Text] [Related]
76. Immediate use of anticoagulants may not improve stroke outcomes.
Am J Health Syst Pharm; 1998 Jun; 55(12):1240. PubMed ID: 9640462
[No Abstract] [Full Text] [Related]
77. College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: the clinical use and laboratory monitoring of low-molecular-weight heparin, danaparoid, hirudin and related compounds, and argatroban.
Laposata M; Green D; Van Cott EM; Barrowcliffe TW; Goodnight SH; Sosolik RC
Arch Pathol Lab Med; 1998 Sep; 122(9):799-807. PubMed ID: 9740137
[TBL] [Abstract][Full Text] [Related]
78. Treatment of heparin-induced thrombocytopenia with thrombosis by new heparinoid.
Harenberg J; Zimmermann R; Schwarz F; Kübler W
Lancet; 1983 Apr; 1(8331):986-7. PubMed ID: 6132291
[No Abstract] [Full Text] [Related]
79. Delayed thrombin generation is not associated with fibrinopeptide formation during prolonged cardiopulmonary bypass with hirudin anticoagulation.
Belway D; Rubens FD; Henley B; Babaev A; Mesana T
Perfusion; 2006 Dec; 21(5):259-62. PubMed ID: 17201079
[TBL] [Abstract][Full Text] [Related]
80. Pregnancy associated with lupus anticoagulant and heparin induced thrombocytopenia: management with a low molecular weight heparinoid.
van Besien K; Hoffman R; Golichowski A
Thromb Res; 1991 Apr; 62(1-2):23-9. PubMed ID: 1712988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
